bpc 157 arginate salt 500mcg BPC-157 — Capsules (30 Count) | Tissue Repair BPC-157 – Mark Hyman, MD

The headline results, as released in the Eli Lilly investor communication and aligned with the study design paper by Giblin and colleagues published in Diabetes, Obesity and Metabolism in 2026, are unusually strong for a Phase 3 obesity trial: Retatrutide 12 mg: mean body-weight reduction of 28.7 percent, roughly 32.3 kg (about 71.2 lbs) from baseline

This medication also slows gastric emptying, which may further reduce nutrient absorption and lead to low energy

It belongs to the class of drugs known as biguanides, which help control blood sugar levels

It works by blocking NNMT, which boosts NAD+ levels and improves the bodys ability to burn stored fat